SCHEMBL4696348

SCHEMBL4696348

O=C(CNCCOC(=O)N(c1ccccc1-c1ccccc1)N1CC[CH]CC1)c1ccc(CN(CCO)CCO)cn1

nearest known ligand 0.38

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PDCD1 Q15116 4/20 0.38
CD274 Q9NZQ7 4/20 0.38
HTR7 P34969 2/20 0.30
HTR1A P08908 1/20 0.30
DRD2 P14416 1/20 0.30
HTR6 P50406 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4695757 0.89 CD274 (0.39) PDCD1CD274
SCHEMBL4696628 0.89 HDAC1 (0.35) PDCD1CD274
SCHEMBL6027369 0.84 OPRM1 (0.37) PDCD1CD274
SCHEMBL4695712 0.84 MEN1 (0.38) PDCD1CD274
SCHEMBL4696800 0.83 CD274 (0.42) PDCD1CD274
SCHEMBL4693066 0.82 KDM4E (0.34) PDCD1CD274
SCHEMBL4695640 0.81 PDCD1 (0.34) PDCD1CD274
SCHEMBL5803928 0.80 MAOB (0.35) PDCD1CD274
SCHEMBL4696335 0.79 PDCD1 (0.44) PDCD1CD274
SCHEMBL4695511 0.78 PDCD1 (0.34) PDCD1CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893577-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2008-03-05 EP claimed
WO-2006138218-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2006-12-28 WO claimed
EP-1893577-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2008-03-05 EP disclosed
WO-2006138218-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2006-12-28 WO disclosed